Portage Biotech Stock Price Prediction

PRTG Stock  USD 4.18  0.03  0.71%   
As of 30th of November 2024, the RSI of Portage Biotech's share price is approaching 35 indicating that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Portage Biotech, making its price go up or down.

Oversold Vs Overbought

35

 
Oversold
 
Overbought
The successful prediction of Portage Biotech's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Portage Biotech and does not consider all of the tangible or intangible factors available from Portage Biotech's fundamental data. We analyze noise-free headlines and recent hype associated with Portage Biotech, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Portage Biotech's stock price prediction:
Wall Street Target Price
140
Using Portage Biotech hype-based prediction, you can estimate the value of Portage Biotech from the perspective of Portage Biotech response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Portage Biotech to buy its stock at a price that has no basis in reality. In that case, they are not buying Portage because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Portage Biotech after-hype prediction price

    
  USD 4.34  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Portage Biotech Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Portage Biotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
0.285.5922.75
Details
1 Analysts
Consensus
LowTargetHigh
9.1010.0011.10
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.000.000.00
Details

Portage Biotech After-Hype Price Prediction Density Analysis

As far as predicting the price of Portage Biotech at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Portage Biotech or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Portage Biotech, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Portage Biotech Estimiated After-Hype Price Volatility

In the context of predicting Portage Biotech's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Portage Biotech's historical news coverage. Portage Biotech's after-hype downside and upside margins for the prediction period are 0.22 and 21.50, respectively. We have considered Portage Biotech's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
4.18
4.34
After-hype Price
21.50
Upside
Portage Biotech is dangerous at this time. Analysis and calculation of next after-hype price of Portage Biotech is based on 3 months time horizon.

Portage Biotech Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Portage Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Portage Biotech backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Portage Biotech, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  1.16 
17.16
  0.16 
  0.04 
2 Events / Month
16 Events / Month
In a few days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
4.18
4.34
3.83 
12,257  
Notes

Portage Biotech Hype Timeline

Portage Biotech is at this time traded for 4.18. The entity has historical hype elasticity of 0.16, and average elasticity to hype of competition of -0.04. Portage is anticipated to increase in value after the next headline, with the price projected to jump to 4.34 or above. The average volatility of media hype impact on the company the price is over 100%. The price rise on the next news is projected to be 3.83%, whereas the daily expected return is at this time at 1.16%. The volatility of related hype on Portage Biotech is about 45365.52%, with the expected price after the next announcement by competition of 4.14. Portage Biotech currently holds 47 K in liabilities. Given the investment horizon of 90 days the next anticipated press release will be in a few days.
Check out Portage Biotech Basic Forecasting Models to cross-verify your projections.
For more detail on how to invest in Portage Stock please use our How to Invest in Portage Biotech guide.

Portage Biotech Related Hype Analysis

Having access to credible news sources related to Portage Biotech's direct competition is more important than ever and may enhance your ability to predict Portage Biotech's future price movements. Getting to know how Portage Biotech's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Portage Biotech may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AMLXAmylyx Pharmaceuticals 0.14 9 per month 4.11  0.27  10.06 (6.13) 33.56 
KRTXKaruna Therapeutics 0.00 0 per month 1.67 (0.04) 3.38 (2.71) 10.01 
BPMCBlueprint Medicines Corp(0.37)10 per month 2.57 (0.02) 4.90 (3.62) 14.28 
ARVNArvinas(0.58)9 per month 3.49 (0.01) 4.85 (5.50) 17.13 
AVTEAerovate Therapeutics(0.02)3 per month 2.04  0.13  5.58 (3.86) 19.11 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.19) 6.21 (9.35) 34.87 
ANEBAnebulo Pharmaceuticals(0.02)5 per month 0.00 (0.02) 8.61 (11.48) 76.00 
CUECue Biopharma(0.11)8 per month 5.91  0.10  20.27 (11.51) 67.78 
DBTXDecibel Therapeutics 0.01 1 per month 4.12  0.05  7.85 (7.45) 26.09 
KROSKeros Therapeutics(0.79)9 per month 2.20  0.1  4.39 (4.31) 16.94 
JANXJanux Therapeutics(1.70)8 per month 2.62 (0.02) 6.87 (4.58) 15.08 
FENCFennec Pharmaceuticals(0.01)11 per month 3.76  0.03  7.14 (6.68) 23.48 
EWTXEdgewise Therapeutics 1.60 10 per month 2.67  0.12  6.65 (4.64) 61.02 
HRMYHarmony Biosciences Holdings 0.96 10 per month 4.24 (0.03) 3.62 (3.53) 34.59 
LCTXLineage Cell Therapeutics 0.01 6 per month 0.00 (0.12) 7.14 (6.25) 39.60 
MAIAMAIA Biotechnology(0.26)6 per month 0.00 (0.06) 8.37 (9.23) 28.10 
ARMPArmata Pharmaceuticals(0.1)3 per month 3.74 (0.02) 6.19 (7.05) 33.83 
FREQFrequency Therapeutics(0.02)2 per month 3.90  0.06  5.71 (6.15) 90.18 
DAWNDay One Biopharmaceuticals 0.27 10 per month 2.77 (0.05) 3.84 (3.69) 11.44 
ABOSAcumen Pharmaceuticals(0.04)8 per month 0.00 (0.07) 7.52 (6.78) 28.07 
XFORX4 Pharmaceuticals 0.02 8 per month 0.00 (0.04) 8.82 (10.61) 62.35 
INZYInozyme Pharma(0.17)9 per month 0.00 (0.31) 5.07 (7.92) 16.62 
VECTVectivBio Holding AG 0.06 7 per month 0.88  0.19  5.61 (3.08) 39.30 

Portage Biotech Additional Predictive Modules

Most predictive techniques to examine Portage price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Portage using various technical indicators. When you analyze Portage charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Portage Biotech Predictive Indicators

The successful prediction of Portage Biotech stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Portage Biotech, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Portage Biotech based on analysis of Portage Biotech hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Portage Biotech's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Portage Biotech's related companies.
 2023 2024 (projected)
Graham Number4.063.86
Receivables Turnover1.061.01

Story Coverage note for Portage Biotech

The number of cover stories for Portage Biotech depends on current market conditions and Portage Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Portage Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Portage Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Portage Biotech Short Properties

Portage Biotech's future price predictability will typically decrease when Portage Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Portage Biotech often depends not only on the future outlook of the potential Portage Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Portage Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding20.3 M
Cash And Short Term InvestmentsM

Complementary Tools for Portage Stock analysis

When running Portage Biotech's price analysis, check to measure Portage Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Portage Biotech is operating at the current time. Most of Portage Biotech's value examination focuses on studying past and present price action to predict the probability of Portage Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Portage Biotech's price. Additionally, you may evaluate how the addition of Portage Biotech to your portfolios can decrease your overall portfolio volatility.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals